Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for management of peritoneal metastases
about
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis.Assessment of clinical benefit and quality of life in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for management of peritoneal carcinomatosis
P2860
Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for management of peritoneal metastases
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Assessment of clinical benefit ...... ement of peritoneal metastases
@en
type
label
Assessment of clinical benefit ...... ement of peritoneal metastases
@en
prefLabel
Assessment of clinical benefit ...... ement of peritoneal metastases
@en
P2093
P2860
P1476
Assessment of clinical benefit ...... ement of peritoneal metastases
@en
P2093
Cherif Boutros
H Richard Alexander
Nader Hanna
P2860
P356
10.3978/J.ISSN.2078-6891.2012.053
P577
2013-03-01T00:00:00Z